Literature DB >> 21222509

Quinoxalin-2-carboxamides: synthesis and pharmacological evaluation as serotonin type-3 (5-HT3) receptor antagonists.

Radhakrishnan Mahesh1, Thangaraj Devadoss, Dilip Kumar Pandey, Shushil Kumar Yadav.   

Abstract

A series of quinoxalin-2-carboxamides were designed as per the pharmacophoric requirements of 5-HT(3) receptor antagonists and synthesized by condensing the carboxylic group of quinoxalin-2-carboxylic acid with various amines in the presence of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 1-hydroxybenzotriazole. The structures of the synthesized compounds were confirmed by physical and spectroscopic data. The carboxamides were evaluated for their 5-HT(3) receptor antagonisms in longitudinal muscle-myenteric plexus preparation from guinea pig ileum against 5-HT(3) agonist, 2-methy-5-HT. All the synthesized compounds showed 5-HT(3) receptor antagonism, (4-benzylpiperazin-1-yl)(quinoxalin-2-yl)methanone was the most potent compound among this series.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222509     DOI: 10.3109/14756366.2010.543419

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  3 in total

1.  Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT(3) receptor antagonist: an investigation in behaviour-based rodent models of depression.

Authors:  Radhakrishnan Mahesh; Baldev Kumar; Ankur Jindal; Shvetank Bhatt; Thangaraj Devadoss; Dilip Kumar Pandey
Journal:  Indian J Pharmacol       Date:  2012 Sep-Oct       Impact factor: 1.200

2.  Anti-anxiety effect of a novel 5-HT₃ receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice.

Authors:  Yeshwant Vijay Kurhe; Mahesh Radhakrishnan; Devadoss Thangaraj; Deepali Gupta
Journal:  Indian J Pharmacol       Date:  2014 Jan-Feb       Impact factor: 1.200

3.  Antidepressant-like effect of a novel 5-HT3 receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests.

Authors:  Yeshwant Kurhe; Radhakrishnan Mahesh; Thangaraj Devadoss; Deepali Gupta
Journal:  J Pharmacol Pharmacother       Date:  2014-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.